Investigation of genome instability in patients with non-alcoholic steatohepatitis

Table 1 Demographic and laboratory parameters of the patient and control groups

Parameter	n	mean	SD	P
Age (yr)				0.977
Patient	25	41.92	13.33
Control	25	41.80	13.09
BMI (kg/m2)				0.001
Patient	25	31.19	4.62
Control	25	25.07	4.14
HOMA-IR				0.001
Patient	25	6.71	4.68
Control	25	1.40	0.53
Hb (g/dL)				0.80
Patient	25	14.73	1.49
Control	25	14.64	1.30
Creatinine (mg/dL)				0.12
Patient	25	0.74	0.15
Control	25	0.80	0.13
AST (U/L)				0.001
Patient	25	56.08	29.11
Control	25	16.88	3.33
ALT (U/L)				0.001
Patient	25	92.20	41.43
Control	25	15.88	5.88
TG (mg/dL)				0.001
Patient	25	219.21	141.68
Control	25	102.56	57.98
HDL (mg/dL)				0.52
Patient	25	46.37	9.65
Control	25	48.72	15.31
LDL (mg/dL)				0.02
Patient	25	136.75	30.14
Control	25	114.63	34.13

BMI: Body mass index; HOMA-IR: Homeostasis model assessment insulin resistance; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; TG: Triglyceride; HDL: High density lipoprotein; LDL: Low density lipoprotein; Hb: Hemoglobin.